Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dallah Healthcare Company (4004.SR)
Riyadh, Riyadh Province, SA
Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company specializes in delivering and managing a comprehensive array of healthcare services and infrastructure. Its core activities encompass the operation, management, outfitting, and growth of hospitals, various medical establishments, polyclinics, residential healthcare complexes, and associated land. Additionally, it supplies essential personnel and ancillary services to both hospitals and medical centers. Beyond direct healthcare provision, Dallah Healthcare is also involved in the production and supply of pharmaceutical, herbal, and cosmetic goods, distributing them to individual pharmacies, health and beauty retailers, hospitals, and government bodies. The firm further extends its expertise to include the oversight and running of hospitals belonging to external entities, alongside offering various supplementary support functions. This encompasses the administration of private hospitals, specialized medical and diagnostic centers, and an analytical laboratory, coupled with the direct provision of medical care. Originally established as Dallah Healthcare Holding Company, the organization officially adopted its current name, Dallah Healthcare Company, in November 2016. Founded in 1994, its corporate headquarters are situated in Riyadh, Saudi Arabia, and it operates as a subsidiary of Dallah Al-Barakah Holding.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.71% | -2.59% | -16.69% | -2.34% | -23.37% | -10.12% | -6.47% | -32.62% | +69.12% | +100.11% | +274.01% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | -1 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+26.9% ★ Q1'26: +21.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+10.1% Q1'26: -47.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+1.3% Q1'26: +0.3% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+13.7% ★ Q1'26: +11.9% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+7.0% ★
-
Share dilution Medical - Care Facilities: +0.0%+3.8% Q1'26: +3.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×5.02× Q1'26: 8.17× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
985.44M
est: 1.00B (-1.7%)
|
1.16B
est: 1.16B (+0.4%)
|
1.21B
est: 1.23B (-1.2%)
|
1.18B
est: 1.18B (-0.1%)
|
1.25B
est: 1.24B (+0.9%)
|
1.32B
est: 1.30B (+1.7%)
|
2.11B
est: 2.07B (+1.7%)
|
2.49B
est: 2.44B (+1.8%)
|
2.94B
est: 3.11B (-5.2%)
|
3.21B
est: 3.32B (-3.4%)
|
4.07B
est: 4.05B (+0.5%)
|
4.55B
4.49B – 4.62B
+12.5% YoY
|
4.96B
4.37B – 5.44B
+8.9% YoY
|
5.52B
5.14B – 5.83B
+11.3% YoY
|
5.82B
5.42B – 6.16B
+5.5% YoY
|
6.12B
5.70B – 6.47B
+5.2% YoY
|
| EBITDA |
226.68M
est: 215.67M (+5.1%)
|
298.12M
est: 249.05M (+19.7%)
|
368.60M
est: 263.79M (+39.7%)
|
220.20M
est: 254.33M (-13.4%)
|
247.06M
est: 267.01M (-7.5%)
|
290.19M
est: 278.72M (+4.1%)
|
448.79M
est: 445.23M (+0.8%)
|
513.89M
est: 525.38M (-2.2%)
|
631.93M
est: 650.73M (-2.9%)
|
707.61M
est: 695.33M (+1.8%)
|
783.50M
est: 848.46M (-7.7%)
|
954.17M
940.32M – 968.01M
+12.5% YoY
|
1.04B
915.61M – 1.14B
+8.9% YoY
|
1.16B
1.08B – 1.22B
+11.3% YoY
|
1.22B
1.14B – 1.29B
+5.5% YoY
|
1.28B
1.19B – 1.36B
+5.2% YoY
|
| EBIT |
179.36M
est: 163.68M (+9.6%)
|
231.00M
est: 189.01M (+22.2%)
|
307.98M
est: 200.19M (+53.8%)
|
156.83M
est: 193.02M (-18.7%)
|
154.39M
est: 202.64M (-23.8%)
|
173.82M
est: 211.53M (-17.8%)
|
333.67M
est: 337.89M (-1.2%)
|
399.63M
est: 398.72M (+0.2%)
|
504.45M
est: 500.21M (+0.8%)
|
567.16M
est: 534.51M (+6.1%)
|
558.81M
est: 652.21M (-14.3%)
|
733.47M
722.83M – 744.12M
+12.5% YoY
|
798.58M
703.83M – 876.64M
+8.9% YoY
|
888.60M
827.64M – 939.92M
+11.3% YoY
|
937.58M
873.25M – 991.73M
+5.5% YoY
|
985.91M
918.27M – 1.04B
+5.2% YoY
|
| Net Income |
165.06M
est: 180.34M (-8.5%)
|
225.83M
est: 250.98M (-10.0%)
|
294.98M
est: 321.04M (-8.1%)
|
141.76M
est: 152.92M (-7.3%)
|
146.92M
est: 128.92M (+14.0%)
|
97.13M
est: 143.82M (-32.5%)
|
258.60M
est: 246.30M (+5.0%)
|
274.46M
est: 307.83M (-10.8%)
|
360.12M
est: 443.60M (-18.8%)
|
471.20M
est: 519.88M (-9.4%)
|
538.00M
est: 532.79M (+1.0%)
|
619.44M
510.87M – 663.30M
+16.3% YoY
|
729.47M
505.50M – 776.28M
+17.8% YoY
|
730.57M
665.41M – 785.42M
+0.1% YoY
|
887.90M
808.71M – 954.57M
+21.5% YoY
|
986.00M
898.06M – 1.06B
+11.0% YoY
|
| SGA |
63.26M
est: 60.13M (+5.2%)
|
64.57M
est: 69.43M (-7.0%)
|
61.15M
est: 73.54M (-16.8%)
|
79.69M
est: 70.90M (+12.4%)
|
70.07M
est: 74.44M (-5.9%)
|
80.40M
est: 77.70M (+3.5%)
|
145.75M
est: 124.12M (+17.4%)
|
152.87M
est: 146.47M (+4.4%)
|
163.21M
est: 148.29M (+10.1%)
|
168.80M
est: 158.46M (+6.5%)
|
—
est: 193.35M (-100.0%)
|
217.44M
214.29M – 220.60M
+12.5% YoY
|
236.74M
208.65M – 259.89M
+8.9% YoY
|
263.43M
245.36M – 278.64M
+11.3% YoY
|
277.95M
258.88M – 294.00M
+5.5% YoY
|
292.28M
272.22M – 309.16M
+5.2% YoY
|
| EPS |
1.84
est: 1.85 (-0.5%)
|
2.50
est: 2.57 (-2.9%)
|
3.28
est: 3.29 (-0.4%)
|
1.58
est: 1.57 (+0.7%)
|
1.69
est: 1.32 (+27.8%)
|
1.13
est: 1.48 (-23.4%)
|
2.87
est: 2.53 (+13.6%)
|
3.05
est: 3.09 (-1.4%)
|
3.70
est: 4.54 (-18.5%)
|
4.83
est: 5.00 (-3.4%)
|
5.32
est: 5.33 (-0.1%)
|
5.99
5.05 – 6.56
+12.4% YoY
|
6.46
5.00 – 7.68
+7.8% YoY
|
7.22
6.58 – 7.77
+11.9% YoY
|
8.78
8.00 – 9.44
+21.5% YoY
|
9.75
8.88 – 10.48
+11.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-10 | B | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-03 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-19 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Saudi Arabia ETF KSA | 0.33% | 2.16M | 0.75% |
| 2 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.06% | 379.6K | 0.55% |
| 3 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.06% | 233.7K | 0.72% |
| 4 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.05% | 180.3K | 0.74% |
| 5 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.02% | 38.9K | 0.07% |
| 6 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.01% | 784.5K | 0.17% |
| 7 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.01% | 784.5K | 0.17% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 83.1K | 0.44% |
| 9 | State Street SPDR Morningstar Multi-Asset Global Infrastructure UCITS ETF (Dist) MAGI.L | 0.01% | 141.3K | 0.40% |
| 10 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.01% | 161.0K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abdulaziz Saleh Al-Wahaibi | Chief Operating Officer | — | — |
| Ahmad bin Saleh Babaeer | Chief Executive Officer | — | — |
| Amin Hariz | Chief Financial Officer | — | — |
| Ismail Abdullah | Chief Digitization Officer | — | — |
| Muteab Abdullah Al Tukeas | C.S.O. | — | — |
| Omar Mohammed Aljabari | Chief Commercial Officer | — | male |
| Salah Rashed Al-Fagih | Chief Medical Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4004.SR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
